MarketInOut Stock Screener Log In | Sign Up
 

Celldex Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/14/2026 13:18
Celldex Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,897.74 mln
Float66.17 mln
Earnings Date11/11/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

74.25
Highly suspicious

1-Year Forecast

58.79
Exceptional upside

Relative Strength

54 / 100
Slightly ahead

Debt / Equity

0.01
Debt-free

Pre-Tax Margin

-190,221%
Severely loss-making

Business Description

Celldex Therapeutics is a New Jersey-based drug development company focused on creating antibody-based treatments for patients suffering from serious inflammatory, allergic, and autoimmune conditions. Its lead programs target diseases driven by mast cells ? a type of immune cell central to allergic responses ? where existing treatments often fall short. The company's pipeline includes two promising drug candidates being studied across conditions such as chronic hives, a severe skin-scratching disorder, and inflammation of the esophagus and skin.

Key Fundamentals

EPS-4.35
ROE-50.91
RPS0.00
ROIC-629
ROA-46.71
EBITDA, mln-322
EV / EBITDA-7.31
EV / EBIT-7.24
Revenue, mln0.16
EV / Revenue14,923

Financial Strength

Altman Z-Score23.41
Piotroski F-Score 1 / 9
Beneish M-Score74.25
1-Year Target Price58.79
Short Ratio10.28
Short % of Float13.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.42% 37 / 100   
1 Month -9.13% 23 / 100   
2 Months 35.29% 93 / 100   
6 Months 31.21% 86 / 100   
1 Year 53.65% 89 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us